Stephen Gitelman, MD
Enriched profileProfessor of Pediatrics and Mary B. Olney, MD / KAK Distinguished Professor in Pediatric Diabetes and Clinical Research, University of California, San Francisco · University of California, San Francisco (UCSF)
Stephen Gitelman is Professor of Pediatrics and Mary B. Olney, MD / KAK Distinguished Professor in Pediatric Diabetes and Clinical Research, University of California, San Francisco at University of California, San Francisco (UCSF). OpenAlex indexes 240 publications with 17,832 citations (h-index 63); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Pediatric Endocrinology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Stephen Gitelman, M.D., is Professor of Pediatrics and Mary B. Olney, MD / KAK Distinguished Professor in Pediatric Diabetes and Clinical Research, University of California, San Francisco. The public record shows 240 publications with 17,832 citations (h-index 63), centered on Diabetes and associated disorders, Diabetes Management and Research, Pancreatic function and diabetes. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 5 companies, 6 NIH-funded awards (1989–2026).
- Most recent indexed publication: 2026 · Diabetologia
- Top research focus: Diabetes and associated disorders
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 127.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
- A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Sponsor: GentiBio, Inc
- HLA Demographics Study in Adults With Type 1 Diabetes
Sponsor: GentiBio, Inc
Industry payments
Updated 18 Oct 2026
5 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20254 payments$18,505openpaymentsdata.cms.gov ↗
- SANOFI US SERVICES INC.Program year20253 payments
- SANOFI-AVENTIS U.S. LLCProgram year20253 payments
NIH funding
Updated 18 Oct 2026
6 NIH research awards on record, funded 1989–2026 per NIH RePORTER. The latest:
- Training Program in Pediatric Endocrinology
University of California, San Francisco
FY2026$297,759T32DK007161 - Training Program in Pediatric Endocrinology
University of California, San Francisco
FY2025$304,981T32DK007161 - Training Program in Pediatric Endocrinology
University of California, San Francisco
FY2024$270,673T32DK007161
Congress activity
Updated 18 Oct 2026
16 congress contributions (2019–2026) across ADA, ENDO per OpenAlex. The most recent:
- 1059-OR: TEPLI-REAL: A Real-World Retrospective Study Characterizing Individuals with Type 1 Diabetes Treated with Teplizumab and Their Metabolic Outcomes
ADA Scientific Sessions
ADA2026Presenting authorOral - 1656-P: TEPLI-REAL: A Real-World Retrospective Study Characterizing Screening and Treatment Patterns for Type 1 Diabetes (T1D) in Individuals Treated with Teplizumab in the U.S.
ADA Scientific Sessions
ADA2026Co-authorPoster - 2392-P: Prevalence of HLA-DRB1*04:01 in U.S. Adults with New-Onset Type 1 Diabetes
ADA Scientific Sessions
ADA2026Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- How to communicate with individuals and caregivers at the time of presymptomatic type 1 diabetes diagnosis.
Postgraduate medicine
Editorial2026
Most-cited works
by citation count (OpenAlex)- 01Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes MellitusArticle1,225 citations2002
- 02An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 DiabetesArticle1,179 citations2019
- 03Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell FunctionArticle1,089 citations2009
- 04Type 1 diabetes immunotherapy using polyclonal regulatory T cellsArticle1,027 citations2015
- 05Toward a molecular understanding of skeletal developmentArticle685 citations1995
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/stephen-gitelman-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
beyondtype1.org/team-members/stephen-gitelman
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →beyondtype1.org ↗ - Other
diabetes.ucsf.edu/people/stephen-gitelman
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetes.ucsf.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
- Undergraduate degree from Princeton University
summa cum laude
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetes.ucsf.edu ↗ - Residency in Pediatrics
University of California, San Francisco
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗ - Board Certified
American Board of Pediatrics, Pediatric Endocrinology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsfbenioffchildrens.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
- Director
Pediatric Diabetes Program, UCSF
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetes.ucsf.edu ↗
Awards & honors
honors on the public record- Mary B. Olney
MD / KAK Distinguished Professorship in Pediatric Diabetes and Clinical Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsfbenioffchildrens.org ↗
Secondary affiliations
appointments beyond the home institution- Clinical Center Director
TrialNet (NIH-sponsored Type 1 Diabetes Research Network)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetes.ucsf.edu ↗ - Investigator
Immune Tolerance Network
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetes.ucsf.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetestechnology.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ids-2013.p.asnevents.com.au ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Gregory Marcus, MD
University of California, San Francisco (UCSF)
Eric Small, MD
University of California, San Francisco (UCSF)
Adam Boxer, MD
University of California, San Francisco (UCSF)
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH